Non-Dilutive Funding
Also known as Non-Dilutive Capital, Non-Dilutive Financing, Equity-Free Funding
Non-dilutive funding is capital that does not require issuing equity in exchange. It includes government grants, R&D tax credits, revenue-based financing, customer prepayments, and certain forms of debt where the lender takes no equity beyond minor warrant coverage.
In depth
Non-dilutive funding is a category, not an instrument. It groups every form of capital that does not require the company to issue new equity in exchange. The economics vary widely across the category, but they share one property: existing ownership stays intact when the money arrives.
The largest single sources are national innovation agency grant programmes. In the United States the SBIR/STTR programme channels grant funding through agencies such as NSF, DoD, NIH, DARPA, and the Department of Energy. In Europe the EIC Accelerator combines grant and blended-finance funding for deep-tech SMEs, and most national governments run their own innovation agency on top of that. Programmes typically run a small proof-of-concept phase followed by a larger commercialisation-oriented phase. Specific caps, eligibility rules, and tax treatment vary by jurisdiction.
The other major sources are R&D tax credits or refunds (most developed jurisdictions offer some form of qualifying-research credit, paid out either as a tax offset or a cash refund for loss-making small businesses), revenue-based financing from specialty lenders, and customer prepayments where a strategic buyer funds product development in exchange for early access. Foundation grants and prize competitions round out the category.
Why it matters
Non-dilutive funding is the cheapest capital on the menu for any company that qualifies. A founder who funds two years of R&D with a few million in grants plus an R&D tax-credit refund has effectively raised a Series A worth of capital without giving up a single share. At a $15M post-money Series A valuation, $3M of non-dilutive funding represents roughly 20% of the company preserved.
The constraint is fit. Innovation grants fund R&D, not sales and marketing. Revenue-based financing requires predictable revenue. R&D tax credits require qualifying research expenditure that survives tax-authority scrutiny. Companies that match their use of funds to the right non-dilutive source can run on it for years; companies that try to fund the wrong activities with the wrong source waste cycles and end up taking equity anyway.
Worked example
A deep-tech hardware startup raises capital across two years using a non-dilutive stack before its Series A:
| Source | Amount | Type | Constraints |
|---|---|---|---|
| National innovation agency, proof-of-concept phase | $300K | Grant | R&D milestones, ~12 months |
| National innovation agency, commercialisation phase | $1.25M | Grant | Prior phase completion required, ~24 months |
| Regional or sector-specific innovation grant | $250K | Grant | Eligibility rules vary by programme |
| R&D tax credit refund | $400K | Cash refund or tax offset | Qualifying R&D expenditure |
| Strategic customer prepayment | $750K | Revenue | Early product access |
Total non-dilutive raised = $2.95M
Equity sold = $0
Implied dilution avoided ≈ $2.95M / $15M target Series A pre ≈ 20%
The founders entered their Series A negotiation owning roughly 20 percentage points more of the company than the same trajectory would have produced via pure equity funding. The math only works because the company's activities were R&D-heavy enough to qualify for the grants and credits in the first place.
Frequently asked
What counts as non-dilutive funding?
Government grants for R&D and innovation, R&D tax credits, revenue-based financing, customer prepayments, and debt facilities without convertible features. Venture debt is partially dilutive because of warrant coverage, but typically transfers under 1% of equity, so many founders include it in the broader non-dilutive category.
How big can government R&D grants be?
Programme caps vary by country and agency. Most national innovation agencies fund early proof-of-concept work at the low-six-figure level and follow-on commercialisation work in the low-seven-figure range. Deep-tech founders frequently stack awards across multiple programmes to accumulate several million in equity-free capital before raising a priced round.
What is revenue-based financing?
A loan repaid as a percentage of monthly revenue until a multiple of the principal has been returned. Common in e-commerce and SaaS where revenue is predictable. No equity changes hands, no fixed monthly payment, and the lender's return scales with the company's growth.
When does non-dilutive funding make sense?
Whenever the cost of capital is lower than the implied cost of equity at the current valuation. Grants are free money for eligible projects. R&D tax credits reclaim cash already spent. Revenue-based financing makes sense when the alternative is selling equity at a price the founder believes will look low in hindsight.